Lexicon Pharmaceuticals (NASDAQ:LXRX) is set to give its latest quarterly earnings report on Thursday, 2026-03-05. Here’s what investors need to know before the announcement.
Analysts estimate that Lexicon Pharmaceuticals will report an earnings per share (EPS) of $-0.07.
Investors in Lexicon Pharmaceuticals are eagerly awaiting the company’s announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It’s worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Earnings History Snapshot
During the last quarter, the company reported an EPS beat by $0.03, leading to a 12.59% drop in the share price on the subsequent day.
Here’s a look at Lexicon Pharmaceuticals’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.07 | -0.08 | -0.10 | -0.12 |
| EPS Actual | -0.04 | 0.01 | -0.07 | -0.09 |
| Price Change % | -12.59 | -2.61 | -15.57 | 6.55 |
Lexicon Pharmaceuticals Share Price Analysis
Shares of Lexicon Pharmaceuticals were trading at $1.61 as of March 03. Over the last 52-week period, …